Robert M. Nerem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert M. Nerem has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Kelvin G.M. Brockbank
Institute for Bioengineering and Bioscience; Georgia Institute of Technology; Atlanta, GA USA
2 shared publications- Stacey C. Schutte
University of Cincinnati
2 shared publications Zhenzhen Chen
Cell & Tissue Systems, Inc.; North Charleston, SC USA
2 shared publications- Adele M. Doyle
Parker H. Petit Institute for Biomedical Engineering and Biosciences, Georgia Institute of Technology, 315 Ferst Drive, Atlanta, GA 30332-0363, USA
1 shared publication Ann E. Ensley
Georgia Tech/Emory Center for the Engineering of Living Tissues, Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA
1 shared publicationDavid V. Schaffer
Department of Chemical Engineering, University of California, Berkeley, Berkeley, California
1 shared publication
Latest Publications
- 14 April 2017
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 356 (6334) , 115
Research integrity revisited
The U.S. public and private sectors invest billions of dollars and countless hours of highly skilled labor into scientific research every year, an investment that delivers enormous benefits to society. Integrity is indispensable to the orderly and efficient progress of this research. Regrettably, there have been some well-publicized breakdowns in scientific integrity and reported cases of irreproducible research. A new report from the U.S. National Academies of Sciences, Engineering, and Medicine (NASEM), Fostering Integrity in Research , recommends specific steps to secure a future based on integrity and reliability ( www.nap.edu/catalog/21896/ ). These include establishing a new Research Integrity Advisory Board (RIAB) and taking stronger actions to discourage and eliminate practices that are clearly detrimental to research.
- 14 April 2017
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 356 (6334) , 115
Research integrity revisited
The U.S. public and private sectors invest billions of dollars and countless hours of highly skilled labor into scientific research every year, an investment that delivers enormous benefits to society. Integrity is indispensable to the orderly and efficient progress of this research. Regrettably, there have been some well-publicized breakdowns in scientific integrity and reported cases of irreproducible research. A new report from the U.S. National Academies of Sciences, Engineering, and Medicine (NASEM), Fostering Integrity in Research , recommends specific steps to secure a future based on integrity and reliability ( www.nap.edu/catalog/21896/ ). These include establishing a new Research Integrity Advisory Board (RIAB) and taking stronger actions to discourage and eliminate practices that are clearly detrimental to research.
- 1 October 2014
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 20 (19-20) , 2575-2589
A Global Assessment of Stem Cell Engineering
Over the last 2 years a global assessment of stem cell engineering (SCE) was conducted with the sponsorship of the National Science Foundation, the National Cancer Institute at the National Institutes of Health, and the National Institute of Standards and Technology. The purpose was to gather information on the worldwide status and trends in SCE, that is, the involvement of engineers and engineering approaches in the stem cell field, both in basic research and in the translation of research into clinical applications and commercial products. The study was facilitated and managed by the World Technology Evaluation Center. The process involved site visits in both Asia and Europe, and it also included several different workshops. From this assessment, the panel concluded that there needs to be an increased role for engineers and the engineering approach. This will provide a foundation for the generation of new markets and future economic growth. To do this will require an increased investment in engineering, applied research, and commercialization as it relates to stem cell research and technology. It also will require programs that support interdisciplinary teams, new innovative mechanisms for academic-industry partnerships, and unique translational models. In addition, the global community would benefit from forming strategic partnerships between countries that can leverage existing and emerging strengths in different institutions. To implement such partnerships will require multinational grant programs with appropriate review mechanisms.
- 1 October 2014
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 20 (19-20) , 2575-2589
A Global Assessment of Stem Cell Engineering
Over the last 2 years a global assessment of stem cell engineering (SCE) was conducted with the sponsorship of the National Science Foundation, the National Cancer Institute at the National Institutes of Health, and the National Institute of Standards and Technology. The purpose was to gather information on the worldwide status and trends in SCE, that is, the involvement of engineers and engineering approaches in the stem cell field, both in basic research and in the translation of research into clinical applications and commercial products. The study was facilitated and managed by the World Technology Evaluation Center. The process involved site visits in both Asia and Europe, and it also included several different workshops. From this assessment, the panel concluded that there needs to be an increased role for engineers and the engineering approach. This will provide a foundation for the generation of new markets and future economic growth. To do this will require an increased investment in engineering, applied research, and commercialization as it relates to stem cell research and technology. It also will require programs that support interdisciplinary teams, new innovative mechanisms for academic-industry partnerships, and unique translational models. In addition, the global community would benefit from forming strategic partnerships between countries that can leverage existing and emerging strengths in different institutions. To implement such partnerships will require multinational grant programs with appropriate review mechanisms.
- 13 May 2014
- Published by Springer Nature
- p. 1-19
Introduction
- 1 March 2014
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 20 (5-6) , 893-894
Stem Cell Engineering
- 1 March 2014
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 20 (5-6) , 893-894
Stem Cell Engineering
- Open Access
- 1 March 2013
- Published by Global Cardiology Science and Practice in Global Cardiology Science and Practice
- Vol. 2013 (1) , 29-36
Bioengineering and the cardiovascular system
The development of the modern era of bioengineering and the advances in our understanding of the cardiovascular system have been intertwined over the past one-half century. This is true of bioengineering as an area for research in universities. Bioengineering is ultimately the beginning of a new engineering discipline, as well as a new discipline in the medical device industry
- 1 March 2013
- Published by Global Cardiology Science and Practice in Global Cardiology Science and Practice
- Vol. 2013 (1) , 29-36
Open AccessBioengineering and the cardiovascular system
The development of the modern era of bioengineering and the advances in our understanding of the cardiovascular system have been intertwined over the past one-half century. This is true of bioengineering as an area for research in universities. Bioengineering is ultimately the beginning of a new engineering discipline, as well as a new discipline in the medical device industry
- 11 September 2012
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 4 (10) , 1263-1273
Effects of shear stress on germ lineage specification of embryonic stem cells
Shear stress applied during early embryonic stem cell differentiation is found to modulate germ lineage specification in a magnitude and duration dependent mann
- 11 September 2012
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 4 (10) , 1263-1273
Effects of shear stress on germ lineage specification of embryonic stem cells
Shear stress applied during early embryonic stem cell differentiation is found to modulate germ lineage specification in a magnitude and duration dependent mann
- 29 November 2011
- Published by Springer Nature in Cellular and Molecular Bioengineering
- Vol. 4 (4) , 507-508
A Tribute to Shu Chien’s Scientific Achievement
- 29 November 2011
- Published by Springer Nature in Cellular and Molecular Bioengineering
- Vol. 4 (4) , 507-508
A Tribute to Shu Chien’s Scientific Achievement
- 27 October 2010
- Published by Taylor & Francis in Organogenesis
- Vol. 6 (4) , 204-211
Tissue engineering of a collagen-based vascular media
The property of vasoactivity is important for both resistance vessels and larger arteries. Evaluation of smooth muscle cell phenotype is often done in place of functional testing in engineered tiss...
- 27 October 2010
- Published by Taylor & Francis in Organogenesis
- Vol. 6 (4) , 204-211
Tissue engineering of a collagen-based vascular media
The property of vasoactivity is important for both resistance vessels and larger arteries. Evaluation of smooth muscle cell phenotype is often done in place of functional testing in engineered tiss...
- 1 October 2010
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 16 (10) , 3149-3157
Cyclic Strain Improves Strength and Function of a Collagen-Based Tissue-Engineered Vascular Media
Tissue-engineered blood vessels may provide a solution to the lack of suitable blood vessels for coronary and peripheral vessel bypass grafting. Cyclic strain can be used to provide a more physiological environment that may result in tissue that more closely resembles native artery. In this study, cyclic strain is applied to a collagen-based, tissue-engineered vascular medium. An increased culture time was used to allow the tissue to adhere to the silastic sleeve and to eliminate longitudinal compaction. Cyclic strain improved tissue strength through increased collagen content as well as some radial tissue compaction. Mechanical stimulation promoted a more contractile phenotype and led to a greater contractile response to the vasoconstrictor endothelin-1.
- 1 October 2010
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 16 (10) , 3149-3157
Cyclic Strain Improves Strength and Function of a Collagen-Based Tissue-Engineered Vascular Media
Tissue-engineered blood vessels may provide a solution to the lack of suitable blood vessels for coronary and peripheral vessel bypass grafting. Cyclic strain can be used to provide a more physiological environment that may result in tissue that more closely resembles native artery. In this study, cyclic strain is applied to a collagen-based, tissue-engineered vascular medium. An increased culture time was used to allow the tissue to adhere to the silastic sleeve and to eliminate longitudinal compaction. Cyclic strain improved tissue strength through increased collagen content as well as some radial tissue compaction. Mechanical stimulation promoted a more contractile phenotype and led to a greater contractile response to the vasoconstrictor endothelin-1.
- 15 September 2010
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 7 (suppl_6) , S771-5
Regenerative medicine: the emergence of an industry
Over the last quarter of a century there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine. There have been ‘ups and downs’ in this industry; however, it now appears to be on a track that may be described as ‘back to the future’. The latest data indicate that for 2007 the private sector activity in the world for this industry is approaching $2.5 billion, with 167 companies/business units and more than 6000 employee full time equivalents. Although small compared with the medical device and also the pharmaceutical industries, these numbers are not insignificant. Thus, there is the indication that this industry, and the related technology, may still achieve its potential and address the needs of millions of patients worldwide, in particular those with needs that currently are unmet.
- 15 September 2010
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 7 (suppl_6) , S771-5
Regenerative medicine: the emergence of an industry
Over the last quarter of a century there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine. There have been ‘ups and downs’ in this industry; however, it now appears to be on a track that may be described as ‘back to the future’. The latest data indicate that for 2007 the private sector activity in the world for this industry is approaching $2.5 billion, with 167 companies/business units and more than 6000 employee full time equivalents. Although small compared with the medical device and also the pharmaceutical industries, these numbers are not insignificant. Thus, there is the indication that this industry, and the related technology, may still achieve its potential and address the needs of millions of patients worldwide, in particular those with needs that currently are unmet.